Late-stage Cervical Cancer Immunotherapy Research Review
Cervical cancer is one of the most common female malignant tumors that threaten Chinese women and even women worldwide.Due to the lack of surgical options for most locally advanced cervical canc-er patients at the time of diagnosis,they can only undergo radiotherapy and chemotherapy.After completing comprehensive treatment,the 5-year survival rate is about 70％,and the 5-year survival rates for patients with pelvic and abdominal lymph node involvement are 34％and 12％respectively.Improving the quality of life and prolonging the survival time of patients is extremely important for advanced and recurrent cervical cancer pa-tients.Therefore,immunotherapy for cervical cancer has become a hot topic in current research.Immunothera-py for cervical cancer has achieved remarkable results in clinical practice,and related clinical studies have con-firmed the clinical benefits of immunotherapy in cervical cancer patients.This review will summarize the re-search progress of immunotherapy for cervical cancer.
万方数据
维普
